Israel Englander Royalty Pharma PLC Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Royalty Pharma PLC stock. As of the latest transaction made, Millennium Management LLC holds 309,170 shares of RPRX stock, worth $10.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

309,170

Previous 133,800 131.07%

Holding current value

$10.2 Million

Previous $3.41 Million 181.98%

% of portfolio

0.01%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	SELL	$25.75 - $33.86 $54.2 Million - $71.3 Million	-2,106,111 Reduced 87.2%	309,170 $9.62 Million
Q4 2024 Feb 14, 2025	SELL	$24.28 - $28.39 $46.8 Million - $54.7 Million	-1,926,224 Reduced 44.37%	2,415,281 $61.6 Million
Q3 2024 Nov 14, 2024	BUY	$25.63 - $29.27 $51 Million - $58.3 Million	1,991,225 Added 84.72%	4,341,505 $123 Million
Q2 2024 Aug 14, 2024	SELL	$26.26 - $29.9 $60.8 Million - $69.3 Million	-2,316,866 Reduced 49.64%	2,350,280 $62 Million
Q1 2024 May 15, 2024	BUY	$27.46 - $31.33 $83.8 Million - $95.6 Million	3,052,745 Added 189.09%	4,667,146 $142 Million
Q4 2023 Feb 14, 2024	SELL	$26.21 - $29.22 $6.84 Million - $7.62 Million	-260,826 Reduced 13.91%	1,614,401 $45.3 Million
Q2 2023 Aug 14, 2023	SELL	$29.6 - $36.56 $4.84 Million - $5.98 Million	-163,655 Reduced 8.03%	1,875,227 $57.6 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $34.6 Million - $41.5 Million	1,054,516 Added 107.13%	2,038,882 $73.5 Million
Q4 2022 Feb 14, 2023	BUY	$39.17 - $44.04 $36.2 Million - $40.7 Million	923,481 Added 1516.76%	984,366 $38.9 Million
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $7.51 Million - $8.41 Million	-188,321 Reduced 75.57%	60,885 $2.45 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $4.16 Million - $4.9 Million	110,837 Added 80.1%	249,206 $10.5 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $3.96 Million - $4.48 Million	105,599 Added 322.24%	138,369 $5.39 Million
Q4 2021 Feb 14, 2022	SELL	$35.17 - $42.48 $24.2 Million - $29.2 Million	-688,414 Reduced 95.46%	32,770 $1.31 Million
Q3 2021 Nov 15, 2021	SELL	$36.14 - $42.24 $1.37 Million - $1.61 Million	-38,016 Reduced 5.01%	721,184 $26.1 Million
Q2 2021 Aug 16, 2021	BUY	$39.85 - $46.63 $23.9 Million - $27.9 Million	599,181 Added 374.44%	759,200 $31.1 Million
Q1 2021 May 17, 2021	BUY	$42.34 - $52.82 $6.78 Million - $8.45 Million	160,019 New	160,019 $6.98 Million
Q4 2020 Feb 16, 2021	SELL	$36.12 - $50.05 $1.57 Million - $2.18 Million	-43,557 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$38.56 - $48.36 $26.2 Million - $32.8 Million	-678,245 Reduced 93.97%	43,557 $1.83 Million
Q2 2020 Aug 14, 2020	BUY	$44.5 - $52.11 $32.1 Million - $37.6 Million	721,802 New	721,802 $35 Million

Others Institutions Holding RPRX

# of Institutions

481

Shares Held

283M

Call Options Held

2.05M

Put Options Held

373K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $14.5B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account